Evidence mapPaperPMID 40969771Full record

ReviewFrontiers in immunology2025

Sensing danger in the islet: the roles of pattern recognition receptors in β cells and type 1 diabetes.

Lixiang Tong, Yiting Tu, Shoujun Huang, Peilin Zheng

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lixiang Tong *Department of General Medicine, People's Hospital of Longhua, Shenzhen, China.
Yiting Tu *Department of Neurology, The Fourth People's Hospital of Shenzhen (Shenzhen Samii Medical Center), Shenzhen, China.
Shoujun HuangSchool of Life Sciences, Anhui Agricultural University, Hefei, China.
Peilin ZhengDepartment of General Medicine, People's Hospital of Longhua, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 1 diabetes (T1D) is an organ-specific autoimmune disease characterized by the immune-mediated destruction of pancreatic β cells, leading to absolute insulin deficiency and chronic hyperglycemia. Traditionally, the onset of T1D has been attributed to the interplay of genetic predisposition and environmental factors that disrupt immune tolerance. However, growing evidence suggests that β cells are not merely passive targets of immune attack. Instead, under conditions of inflammatory and metabolic stress, β cells actively participate in immune modulation by upregulating various immunologically relevant molecules, particularly pattern recognition receptors (PRRs). These innate immune sensors enable β cells to detect danger-associated signals and modulate local immune responses, thereby influencing their survival and immunogenicity. In this review, we summarize current knowledge about the expression profiles and immunoregulatory roles of PRRs in pancreatic β cells and explore their potential contributions to T1D pathogenesis. A deeper understanding of PRR-mediated signaling in β cells may provide novel insights into the immunopathology of T1D and reveal promising targets for therapeutic intervention.

Indexed as

Diabetes Mellitus, Type 1Insulin-Secreting CellsReceptors, Pattern RecognitionAnimalsHumansImmunity, InnateSignal TransductionReceptors, Pattern Recognitionautoimmunityinnate immunitypancreatic β cellspattern recognition receptorstype 1 diabetes

Identifiers

PMID40969771
PMCPMC12441050

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.